RS

Ravi Sinha

Active Director Director DIN 06829826
DIN 06829826 First appointment Aug 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value •••• Premium profile

About Ravi Sinha

Data last updated:

Ravi Sinha is a Director at Umera Health Care Private Limited (since 2018). The company operates in Healthcare. Umera Health Care Private Limited reported revenue of ₹98.4 Lakh (FY 2024).

DIN 06829826
Primary Designation Director
Industry Healthcare
First Appointment 14 Aug 2018
Oldest Company Age 8 yrs
Largest company Umera Health Care Private Limited · ₹98.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Umera Health Care Private Limited U85200BR2018PTC038944
Director14 Aug 20182018₹98.4 Lakh (FY 2024)Active

Board colleagues of Ravi Sinha

Directorship timeline

Open interactive timeline →
Umera Health Care Private Limited
Premium access

Shareholding and investment profile for Ravi Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Sinha

Ravi Sinha currently holds 1 directorship: Umera Health Care Private Limited (Director, since 14 Aug 2018, revenue ₹98.4 Lakh (FY 2024)).

Ravi Sinha was first appointed on 14 Aug 2018 as Director at Umera Health Care Private Limited.

The current boards of Ravi Sinha's companies include Chandra Prakash (Umera Health Care Private Limited), Mohammad Nezamuddin Khan (Umera Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available